Description
BSE lists 3,11,111 new equity shares of Vivo Bio Tech Ltd issued on preferential basis to promoters at Rs. 45 per share with lock-in until February 2027.
Summary
BSE has approved the listing of 3,11,111 new equity shares of Vivo Bio Tech Ltd (Scrip Code: 511509) issued to promoters on a preferential basis. The shares, issued at Rs. 45 per share, are the result of warrant conversion and will commence trading on August 6, 2025.
Key Points
- 3,11,111 equity shares of Rs. 10 face value issued at Rs. 35 premium
- Shares issued to promoters on preferential basis pursuant to warrant conversion
- Issue price: Rs. 45 per share
- Allotment date: April 8, 2025
- Trading commencement: August 6, 2025
- ISIN: INE380K01017
- Distinguished numbers: 17164817 to 17475927
Regulatory Changes
No regulatory changes introduced. This is a standard listing notification following warrant conversion.
Compliance Requirements
- Trading members informed of new securities availability
- Shares subject to lock-in provisions until February 28, 2027
- All 3,11,111 shares under lock-in restriction
Important Dates
- Allotment Date: April 8, 2025
- Trading Commencement: August 6, 2025
- Lock-in Expiry: February 28, 2027
Impact Assessment
Minimal market impact expected as shares are issued to promoters with extended lock-in period. The preferential allotment increases the company’s equity base but shares cannot be traded until February 2027, limiting immediate market liquidity effects.
Impact Justification
Standard listing notification for preferential allotment with significant lock-in period